Latest debt-to-equity ratio
Zentalis Pharmaceuticals Debt-to-equity ratio
Direct answer
Zentalis Pharmaceuticals's debt-to-equity ratio is 26.24%.
The verified market snapshot reports 26.24%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 24, 2026.
Get free Zentalis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 26.24%
Explore related company data
View Zentalis Pharmaceuticals's market capitalizationView Zentalis Pharmaceuticals's price-to-book ratioView Zentalis Pharmaceuticals's return on equityView Zentalis Pharmaceuticals's dividend yieldView Zentalis Pharmaceuticals's 52-week price rangeView Zentalis Pharmaceuticals's profit marginView all Zentalis Pharmaceuticals key metricsReturn to Zentalis Pharmaceuticals profile